Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000863750 | SCV001004460 | benign | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2024-12-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002478959 | SCV002802178 | likely benign | Homocystinuria due to methylene tetrahydrofolate reductase deficiency; Neural tube defects, folate-sensitive; Schizophrenia; Thrombophilia due to thrombin defect | 2021-07-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001579355 | SCV005286552 | benign | not provided | criteria provided, single submitter | not provided | ||
Centre de Biologie Pathologie Génétique, |
RCV001252319 | SCV001428071 | likely benign | Intellectual disability | 2019-01-01 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000863750 | SCV001459044 | uncertain significance | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2020-01-09 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001579355 | SCV001806899 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001579355 | SCV001919136 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001579355 | SCV001973307 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003938250 | SCV004747223 | likely benign | MTHFR-related disorder | 2023-10-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |